nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—ATP1A1—coronary artery disease	0.792	1	CbGaD
Bretylium—SLC6A2—sympathetic nervous system—coronary artery disease	0.00568	0.371	CbGeAlD
Bretylium—SLC6A2—autonomic nervous system—coronary artery disease	0.00382	0.249	CbGeAlD
Bretylium—ATP1A1—Ion transport by P-type ATPases—FXYD1—coronary artery disease	0.00256	0.0762	CbGpPWpGaD
Bretylium—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A6—coronary artery disease	0.00181	0.0538	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—TBX3—coronary artery disease	0.0018	0.0534	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—PLN—coronary artery disease	0.00177	0.0528	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP4A—coronary artery disease	0.00158	0.0471	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP2B1—coronary artery disease	0.0014	0.0417	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—NR3C2—coronary artery disease	0.0014	0.0416	CbGpPWpGaD
Bretylium—ATP1A1—cardiac ventricle—coronary artery disease	0.00137	0.0892	CbGeAlD
Bretylium—ATP1A1—Preimplantation Embryo—ZFP36—coronary artery disease	0.00136	0.0405	CbGpPWpGaD
Bretylium—ATP1A1—myocardium—coronary artery disease	0.00128	0.0839	CbGeAlD
Bretylium—SLC6A2—Amine compound SLC transporters—SLC6A6—coronary artery disease	0.00126	0.0374	CbGpPWpGaD
Bretylium—ATP1A1—Preimplantation Embryo—KLF4—coronary artery disease	0.00124	0.037	CbGpPWpGaD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP2A2—coronary artery disease	0.000993	0.0295	CbGpPWpGaD
Bretylium—ATP1A1—heart—coronary artery disease	0.000897	0.0585	CbGeAlD
Bretylium—ATP1A1—Ion channel transport—FXYD1—coronary artery disease	0.000886	0.0264	CbGpPWpGaD
Bretylium—ATP1A1—cardiovascular system—coronary artery disease	0.000846	0.0552	CbGeAlD
Bretylium—ATP1A1—cardiac atrium—coronary artery disease	0.000767	0.0501	CbGeAlD
Bretylium—ATP1A1—blood—coronary artery disease	0.000669	0.0437	CbGeAlD
Bretylium—ATP1A1—Ion channel transport—RYR2—coronary artery disease	0.000631	0.0188	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—PLN—coronary artery disease	0.000614	0.0183	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—CES3—coronary artery disease	0.00055	0.0164	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—PRDX6—coronary artery disease	0.00055	0.0164	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP4A—coronary artery disease	0.000547	0.0163	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A6—coronary artery disease	0.000491	0.0146	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP2B1—coronary artery disease	0.000485	0.0144	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC6A6—coronary artery disease	0.000354	0.0105	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—ATP2A2—coronary artery disease	0.000344	0.0102	CbGpPWpGaD
Bretylium—Shock—Valsartan—coronary artery disease	0.000336	0.00211	CcSEcCtD
Bretylium—Loss of consciousness—Telmisartan—coronary artery disease	0.000336	0.00211	CcSEcCtD
Bretylium—Dizziness—Ticagrelor—coronary artery disease	0.000336	0.00211	CcSEcCtD
Bretylium—Shock—Olmesartan—coronary artery disease	0.000335	0.0021	CcSEcCtD
Bretylium—Syncope—Captopril—coronary artery disease	0.000334	0.0021	CcSEcCtD
Bretylium—Bradycardia—Timolol—coronary artery disease	0.000332	0.00209	CcSEcCtD
Bretylium—Dyspnoea—Eplerenone—coronary artery disease	0.000331	0.00208	CcSEcCtD
Bretylium—Anxiety—Trandolapril—coronary artery disease	0.000331	0.00208	CcSEcCtD
Bretylium—Hypertension—Telmisartan—coronary artery disease	0.00033	0.00208	CcSEcCtD
Bretylium—Vomiting—Gemfibrozil—coronary artery disease	0.00033	0.00207	CcSEcCtD
Bretylium—Confusional state—Pravastatin—coronary artery disease	0.00033	0.00207	CcSEcCtD
Bretylium—Hyperhidrosis—Olmesartan—coronary artery disease	0.000329	0.00207	CcSEcCtD
Bretylium—Shock—Niacin—coronary artery disease	0.000327	0.00205	CcSEcCtD
Bretylium—Loss of consciousness—Captopril—coronary artery disease	0.000327	0.00205	CcSEcCtD
Bretylium—Feeling abnormal—Fenofibrate—coronary artery disease	0.000327	0.00205	CcSEcCtD
Bretylium—Anxiety—Telmisartan—coronary artery disease	0.000325	0.00204	CcSEcCtD
Bretylium—Vertigo—Perindopril—coronary artery disease	0.000325	0.00204	CcSEcCtD
Bretylium—Gastrointestinal pain—Fenofibrate—coronary artery disease	0.000324	0.00204	CcSEcCtD
Bretylium—Syncope—Perindopril—coronary artery disease	0.000324	0.00203	CcSEcCtD
Bretylium—Dyspnoea—Simvastatin—coronary artery disease	0.000323	0.00203	CcSEcCtD
Bretylium—Vomiting—Ticagrelor—coronary artery disease	0.000323	0.00203	CcSEcCtD
Bretylium—Hyperhidrosis—Niacin—coronary artery disease	0.000321	0.00202	CcSEcCtD
Bretylium—Feeling abnormal—Clopidogrel—coronary artery disease	0.000321	0.00202	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—ITGB3—coronary artery disease	0.000321	0.00954	CbGpPWpGaD
Bretylium—Confusional state—Enalapril—coronary artery disease	0.000319	0.00201	CcSEcCtD
Bretylium—Feeling abnormal—Lovastatin—coronary artery disease	0.000319	0.002	CcSEcCtD
Bretylium—Gastrointestinal pain—Clopidogrel—coronary artery disease	0.000319	0.002	CcSEcCtD
Bretylium—Loss of consciousness—Perindopril—coronary artery disease	0.000318	0.00199	CcSEcCtD
Bretylium—Gastrointestinal pain—Lovastatin—coronary artery disease	0.000317	0.00199	CcSEcCtD
Bretylium—Hyperhidrosis—Pravastatin—coronary artery disease	0.000317	0.00199	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—coronary artery disease	0.000316	0.00942	CbGpPWpGaD
Bretylium—Vertigo—Furosemide—coronary artery disease	0.000316	0.00198	CcSEcCtD
Bretylium—Abdominal pain—Fenofibrate—coronary artery disease	0.000313	0.00197	CcSEcCtD
Bretylium—Body temperature increased—Fenofibrate—coronary artery disease	0.000313	0.00197	CcSEcCtD
Bretylium—Feeling abnormal—Ezetimibe—coronary artery disease	0.000313	0.00197	CcSEcCtD
Bretylium—Shock—Trandolapril—coronary artery disease	0.000313	0.00196	CcSEcCtD
Bretylium—Diarrhoea—Rosuvastatin—coronary artery disease	0.000313	0.00196	CcSEcCtD
Bretylium—Hypertension—Perindopril—coronary artery disease	0.000312	0.00196	CcSEcCtD
Bretylium—Shock—Enalapril—coronary artery disease	0.000312	0.00196	CcSEcCtD
Bretylium—Gastrointestinal pain—Ezetimibe—coronary artery disease	0.000311	0.00195	CcSEcCtD
Bretylium—Flushing—Ramipril—coronary artery disease	0.00031	0.00195	CcSEcCtD
Bretylium—Nausea—Gemfibrozil—coronary artery disease	0.000309	0.00194	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000308	0.00917	CbGpPWpGaD
Bretylium—Bradycardia—Lisinopril—coronary artery disease	0.000308	0.00194	CcSEcCtD
Bretylium—Body temperature increased—Clopidogrel—coronary artery disease	0.000308	0.00194	CcSEcCtD
Bretylium—Abdominal pain—Clopidogrel—coronary artery disease	0.000308	0.00194	CcSEcCtD
Bretylium—Hyperhidrosis—Trandolapril—coronary artery disease	0.000307	0.00193	CcSEcCtD
Bretylium—Shock—Telmisartan—coronary artery disease	0.000307	0.00193	CcSEcCtD
Bretylium—Anxiety—Perindopril—coronary artery disease	0.000307	0.00193	CcSEcCtD
Bretylium—Feeling abnormal—Eplerenone—coronary artery disease	0.000306	0.00192	CcSEcCtD
Bretylium—Confusional state—Captopril—coronary artery disease	0.000306	0.00192	CcSEcCtD
Bretylium—Hyperhidrosis—Enalapril—coronary artery disease	0.000306	0.00192	CcSEcCtD
Bretylium—Body temperature increased—Lovastatin—coronary artery disease	0.000306	0.00192	CcSEcCtD
Bretylium—Abdominal pain—Lovastatin—coronary artery disease	0.000306	0.00192	CcSEcCtD
Bretylium—Dyspnoea—Valsartan—coronary artery disease	0.000305	0.00191	CcSEcCtD
Bretylium—Vertigo—Losartan—coronary artery disease	0.000305	0.00191	CcSEcCtD
Bretylium—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000304	0.00191	CcSEcCtD
Bretylium—Syncope—Losartan—coronary artery disease	0.000304	0.00191	CcSEcCtD
Bretylium—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000304	0.00191	CcSEcCtD
Bretylium—Dizziness—Rosuvastatin—coronary artery disease	0.000302	0.0019	CcSEcCtD
Bretylium—Hyperhidrosis—Telmisartan—coronary artery disease	0.000302	0.0019	CcSEcCtD
Bretylium—Nausea—Ticagrelor—coronary artery disease	0.000301	0.00189	CcSEcCtD
Bretylium—Abdominal pain—Ezetimibe—coronary artery disease	0.0003	0.00189	CcSEcCtD
Bretylium—Body temperature increased—Ezetimibe—coronary artery disease	0.0003	0.00189	CcSEcCtD
Bretylium—Shock—Captopril—coronary artery disease	0.000299	0.00188	CcSEcCtD
Bretylium—Feeling abnormal—Simvastatin—coronary artery disease	0.000298	0.00187	CcSEcCtD
Bretylium—Loss of consciousness—Losartan—coronary artery disease	0.000298	0.00187	CcSEcCtD
Bretylium—Confusional state—Perindopril—coronary artery disease	0.000297	0.00187	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GSTM2—coronary artery disease	0.000297	0.00883	CbGpPWpGaD
Bretylium—Dyspnoea—Niacin—coronary artery disease	0.000296	0.00186	CcSEcCtD
Bretylium—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000296	0.00186	CcSEcCtD
Bretylium—Body temperature increased—Eplerenone—coronary artery disease	0.000294	0.00185	CcSEcCtD
Bretylium—Abdominal pain—Eplerenone—coronary artery disease	0.000294	0.00185	CcSEcCtD
Bretylium—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000294	0.00184	CcSEcCtD
Bretylium—Dyspnoea—Pravastatin—coronary artery disease	0.000292	0.00183	CcSEcCtD
Bretylium—Shock—Perindopril—coronary artery disease	0.00029	0.00182	CcSEcCtD
Bretylium—Confusional state—Furosemide—coronary artery disease	0.000289	0.00182	CcSEcCtD
Bretylium—Anxiety—Losartan—coronary artery disease	0.000288	0.00181	CcSEcCtD
Bretylium—Body temperature increased—Simvastatin—coronary artery disease	0.000286	0.0018	CcSEcCtD
Bretylium—Abdominal pain—Simvastatin—coronary artery disease	0.000286	0.0018	CcSEcCtD
Bretylium—Hyperhidrosis—Perindopril—coronary artery disease	0.000285	0.00179	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—AGT—coronary artery disease	0.000284	0.00845	CbGpPWpGaD
Bretylium—Dyspnoea—Trandolapril—coronary artery disease	0.000283	0.00178	CcSEcCtD
Bretylium—Dyspnoea—Enalapril—coronary artery disease	0.000282	0.00177	CcSEcCtD
Bretylium—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000282	0.00177	CcSEcCtD
Bretylium—Shock—Furosemide—coronary artery disease	0.000282	0.00177	CcSEcCtD
Bretylium—Flushing—Lisinopril—coronary artery disease	0.000281	0.00176	CcSEcCtD
Bretylium—Feeling abnormal—Olmesartan—coronary artery disease	0.00028	0.00176	CcSEcCtD
Bretylium—Gastrointestinal pain—Valsartan—coronary artery disease	0.00028	0.00176	CcSEcCtD
Bretylium—Confusional state—Losartan—coronary artery disease	0.000279	0.00175	CcSEcCtD
Bretylium—Dyspnoea—Telmisartan—coronary artery disease	0.000278	0.00175	CcSEcCtD
Bretylium—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000278	0.00175	CcSEcCtD
Bretylium—Hyperhidrosis—Furosemide—coronary artery disease	0.000277	0.00174	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000275	0.00818	CbGpPWpGaD
Bretylium—Shock—Losartan—coronary artery disease	0.000272	0.00171	CcSEcCtD
Bretylium—Gastrointestinal pain—Niacin—coronary artery disease	0.000272	0.00171	CcSEcCtD
Bretylium—Nausea—Rosuvastatin—coronary artery disease	0.000271	0.0017	CcSEcCtD
Bretylium—Diarrhoea—Fenofibrate—coronary artery disease	0.000271	0.0017	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—MAPK14—coronary artery disease	0.000271	0.00806	CbGpPWpGaD
Bretylium—Dyspnoea—Captopril—coronary artery disease	0.000271	0.0017	CcSEcCtD
Bretylium—Abdominal pain—Valsartan—coronary artery disease	0.00027	0.0017	CcSEcCtD
Bretylium—Feeling abnormal—Pravastatin—coronary artery disease	0.00027	0.00169	CcSEcCtD
Bretylium—Abdominal pain—Olmesartan—coronary artery disease	0.000269	0.00169	CcSEcCtD
Bretylium—Body temperature increased—Olmesartan—coronary artery disease	0.000269	0.00169	CcSEcCtD
Bretylium—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000268	0.00168	CcSEcCtD
Bretylium—Hyperhidrosis—Losartan—coronary artery disease	0.000267	0.00168	CcSEcCtD
Bretylium—Diarrhoea—Clopidogrel—coronary artery disease	0.000267	0.00167	CcSEcCtD
Bretylium—Diarrhoea—Lovastatin—coronary artery disease	0.000265	0.00166	CcSEcCtD
Bretylium—Nausea—Acetylsalicylic acid—coronary artery disease	0.000264	0.00166	CcSEcCtD
Bretylium—Dyspnoea—Perindopril—coronary artery disease	0.000263	0.00165	CcSEcCtD
Bretylium—Body temperature increased—Niacin—coronary artery disease	0.000263	0.00165	CcSEcCtD
Bretylium—Abdominal pain—Niacin—coronary artery disease	0.000263	0.00165	CcSEcCtD
Bretylium—Dizziness—Fenofibrate—coronary artery disease	0.000262	0.00165	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000262	0.0078	CbGpPWpGaD
Bretylium—Feeling abnormal—Trandolapril—coronary artery disease	0.000262	0.00165	CcSEcCtD
Bretylium—Vertigo—Ramipril—coronary artery disease	0.000261	0.00164	CcSEcCtD
Bretylium—Feeling abnormal—Enalapril—coronary artery disease	0.000261	0.00164	CcSEcCtD
Bretylium—Syncope—Ramipril—coronary artery disease	0.000261	0.00164	CcSEcCtD
Bretylium—Gastrointestinal pain—Trandolapril—coronary artery disease	0.00026	0.00163	CcSEcCtD
Bretylium—Diarrhoea—Ezetimibe—coronary artery disease	0.00026	0.00163	CcSEcCtD
Bretylium—Gastrointestinal pain—Enalapril—coronary artery disease	0.000259	0.00163	CcSEcCtD
Bretylium—Body temperature increased—Pravastatin—coronary artery disease	0.000259	0.00163	CcSEcCtD
Bretylium—Abdominal pain—Pravastatin—coronary artery disease	0.000259	0.00163	CcSEcCtD
Bretylium—Dizziness—Clopidogrel—coronary artery disease	0.000258	0.00162	CcSEcCtD
Bretylium—Feeling abnormal—Telmisartan—coronary artery disease	0.000257	0.00162	CcSEcCtD
Bretylium—Dizziness—Lovastatin—coronary artery disease	0.000256	0.00161	CcSEcCtD
Bretylium—Loss of consciousness—Ramipril—coronary artery disease	0.000255	0.0016	CcSEcCtD
Bretylium—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000255	0.0016	CcSEcCtD
Bretylium—Vertigo—Timolol—coronary artery disease	0.000255	0.0016	CcSEcCtD
Bretylium—Syncope—Timolol—coronary artery disease	0.000255	0.0016	CcSEcCtD
Bretylium—Diarrhoea—Eplerenone—coronary artery disease	0.000254	0.0016	CcSEcCtD
Bretylium—Vomiting—Fenofibrate—coronary artery disease	0.000252	0.00158	CcSEcCtD
Bretylium—Abdominal pain—Trandolapril—coronary artery disease	0.000251	0.00158	CcSEcCtD
Bretylium—Body temperature increased—Trandolapril—coronary artery disease	0.000251	0.00158	CcSEcCtD
Bretylium—Dizziness—Ezetimibe—coronary artery disease	0.000251	0.00158	CcSEcCtD
Bretylium—Body temperature increased—Enalapril—coronary artery disease	0.00025	0.00157	CcSEcCtD
Bretylium—Abdominal pain—Enalapril—coronary artery disease	0.00025	0.00157	CcSEcCtD
Bretylium—Feeling abnormal—Captopril—coronary artery disease	0.00025	0.00157	CcSEcCtD
Bretylium—Loss of consciousness—Timolol—coronary artery disease	0.00025	0.00157	CcSEcCtD
Bretylium—Gastrointestinal pain—Captopril—coronary artery disease	0.000248	0.00156	CcSEcCtD
Bretylium—Vomiting—Clopidogrel—coronary artery disease	0.000248	0.00156	CcSEcCtD
Bretylium—Diarrhoea—Simvastatin—coronary artery disease	0.000248	0.00156	CcSEcCtD
Bretylium—Body temperature increased—Telmisartan—coronary artery disease	0.000247	0.00155	CcSEcCtD
Bretylium—Abdominal pain—Telmisartan—coronary artery disease	0.000247	0.00155	CcSEcCtD
Bretylium—Dyspnoea—Losartan—coronary artery disease	0.000247	0.00155	CcSEcCtD
Bretylium—Anxiety—Ramipril—coronary artery disease	0.000247	0.00155	CcSEcCtD
Bretylium—Vomiting—Lovastatin—coronary artery disease	0.000246	0.00155	CcSEcCtD
Bretylium—Dizziness—Eplerenone—coronary artery disease	0.000246	0.00154	CcSEcCtD
Bretylium—Hypertension—Timolol—coronary artery disease	0.000245	0.00154	CcSEcCtD
Bretylium—Feeling abnormal—Perindopril—coronary artery disease	0.000243	0.00153	CcSEcCtD
Bretylium—Vomiting—Ezetimibe—coronary artery disease	0.000241	0.00152	CcSEcCtD
Bretylium—Gastrointestinal pain—Perindopril—coronary artery disease	0.000241	0.00151	CcSEcCtD
Bretylium—Anxiety—Timolol—coronary artery disease	0.000241	0.00151	CcSEcCtD
Bretylium—Body temperature increased—Captopril—coronary artery disease	0.00024	0.00151	CcSEcCtD
Bretylium—Abdominal pain—Captopril—coronary artery disease	0.00024	0.00151	CcSEcCtD
Bretylium—Dizziness—Simvastatin—coronary artery disease	0.000239	0.0015	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GCLM—coronary artery disease	0.000239	0.00712	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SOD3—coronary artery disease	0.000239	0.00712	CbGpPWpGaD
Bretylium—Confusional state—Ramipril—coronary artery disease	0.000239	0.0015	CcSEcCtD
Bretylium—Vertigo—Lisinopril—coronary artery disease	0.000237	0.00149	CcSEcCtD
Bretylium—Syncope—Lisinopril—coronary artery disease	0.000236	0.00148	CcSEcCtD
Bretylium—Vomiting—Eplerenone—coronary artery disease	0.000236	0.00148	CcSEcCtD
Bretylium—Feeling abnormal—Furosemide—coronary artery disease	0.000236	0.00148	CcSEcCtD
Bretylium—Nausea—Fenofibrate—coronary artery disease	0.000236	0.00148	CcSEcCtD
Bretylium—Gastrointestinal pain—Furosemide—coronary artery disease	0.000234	0.00147	CcSEcCtD
Bretylium—Diarrhoea—Valsartan—coronary artery disease	0.000234	0.00147	CcSEcCtD
Bretylium—Confusional state—Timolol—coronary artery disease	0.000234	0.00147	CcSEcCtD
Bretylium—Shock—Ramipril—coronary artery disease	0.000233	0.00147	CcSEcCtD
Bretylium—Body temperature increased—Perindopril—coronary artery disease	0.000233	0.00146	CcSEcCtD
Bretylium—Abdominal pain—Perindopril—coronary artery disease	0.000233	0.00146	CcSEcCtD
Bretylium—Diarrhoea—Olmesartan—coronary artery disease	0.000233	0.00146	CcSEcCtD
Bretylium—Loss of consciousness—Lisinopril—coronary artery disease	0.000232	0.00145	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—TXNRD1—coronary artery disease	0.000232	0.00689	CbGpPWpGaD
Bretylium—Nausea—Clopidogrel—coronary artery disease	0.000232	0.00145	CcSEcCtD
Bretylium—Vomiting—Simvastatin—coronary artery disease	0.00023	0.00145	CcSEcCtD
Bretylium—Nausea—Lovastatin—coronary artery disease	0.00023	0.00144	CcSEcCtD
Bretylium—Hyperhidrosis—Ramipril—coronary artery disease	0.000229	0.00144	CcSEcCtD
Bretylium—Shock—Timolol—coronary artery disease	0.000228	0.00143	CcSEcCtD
Bretylium—Feeling abnormal—Losartan—coronary artery disease	0.000228	0.00143	CcSEcCtD
Bretylium—Diarrhoea—Niacin—coronary artery disease	0.000228	0.00143	CcSEcCtD
Bretylium—Body temperature increased—Furosemide—coronary artery disease	0.000227	0.00142	CcSEcCtD
Bretylium—Abdominal pain—Furosemide—coronary artery disease	0.000227	0.00142	CcSEcCtD
Bretylium—Gastrointestinal pain—Losartan—coronary artery disease	0.000226	0.00142	CcSEcCtD
Bretylium—Dizziness—Valsartan—coronary artery disease	0.000226	0.00142	CcSEcCtD
Bretylium—Nausea—Ezetimibe—coronary artery disease	0.000226	0.00142	CcSEcCtD
Bretylium—Dizziness—Olmesartan—coronary artery disease	0.000225	0.00141	CcSEcCtD
Bretylium—Hyperhidrosis—Timolol—coronary artery disease	0.000224	0.00141	CcSEcCtD
Bretylium—Diarrhoea—Pravastatin—coronary artery disease	0.000224	0.00141	CcSEcCtD
Bretylium—Anxiety—Lisinopril—coronary artery disease	0.000224	0.0014	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.000223	0.00664	CbGpPWpGaD
Bretylium—Nausea—Eplerenone—coronary artery disease	0.000221	0.00139	CcSEcCtD
Bretylium—Dizziness—Niacin—coronary artery disease	0.00022	0.00138	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.00022	0.00654	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.00022	0.00654	CbGpPWpGaD
Bretylium—Abdominal pain—Losartan—coronary artery disease	0.000219	0.00137	CcSEcCtD
Bretylium—Body temperature increased—Losartan—coronary artery disease	0.000219	0.00137	CcSEcCtD
Bretylium—Diarrhoea—Trandolapril—coronary artery disease	0.000218	0.00137	CcSEcCtD
Bretylium—Vomiting—Valsartan—coronary artery disease	0.000217	0.00137	CcSEcCtD
Bretylium—Confusional state—Lisinopril—coronary artery disease	0.000217	0.00136	CcSEcCtD
Bretylium—Diarrhoea—Enalapril—coronary artery disease	0.000217	0.00136	CcSEcCtD
Bretylium—Dizziness—Pravastatin—coronary artery disease	0.000217	0.00136	CcSEcCtD
Bretylium—Vomiting—Olmesartan—coronary artery disease	0.000216	0.00136	CcSEcCtD
Bretylium—Nausea—Simvastatin—coronary artery disease	0.000215	0.00135	CcSEcCtD
Bretylium—Diarrhoea—Telmisartan—coronary artery disease	0.000214	0.00134	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000214	0.00636	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GPX2—coronary artery disease	0.000213	0.00634	CbGpPWpGaD
Bretylium—Shock—Lisinopril—coronary artery disease	0.000212	0.00133	CcSEcCtD
Bretylium—Dyspnoea—Ramipril—coronary artery disease	0.000211	0.00133	CcSEcCtD
Bretylium—Vomiting—Niacin—coronary artery disease	0.000211	0.00133	CcSEcCtD
Bretylium—Dizziness—Trandolapril—coronary artery disease	0.00021	0.00132	CcSEcCtD
Bretylium—Dizziness—Enalapril—coronary artery disease	0.000209	0.00132	CcSEcCtD
Bretylium—Vomiting—Pravastatin—coronary artery disease	0.000208	0.00131	CcSEcCtD
Bretylium—Hyperhidrosis—Lisinopril—coronary artery disease	0.000208	0.00131	CcSEcCtD
Bretylium—Diarrhoea—Captopril—coronary artery disease	0.000208	0.00131	CcSEcCtD
Bretylium—Dyspnoea—Timolol—coronary artery disease	0.000207	0.0013	CcSEcCtD
Bretylium—Dizziness—Telmisartan—coronary artery disease	0.000207	0.0013	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GSTA1—coronary artery disease	0.000206	0.00612	CbGpPWpGaD
Bretylium—Nausea—Valsartan—coronary artery disease	0.000203	0.00128	CcSEcCtD
Bretylium—Nausea—Olmesartan—coronary artery disease	0.000202	0.00127	CcSEcCtD
Bretylium—Vomiting—Trandolapril—coronary artery disease	0.000202	0.00127	CcSEcCtD
Bretylium—Diarrhoea—Perindopril—coronary artery disease	0.000202	0.00127	CcSEcCtD
Bretylium—Vomiting—Enalapril—coronary artery disease	0.000201	0.00126	CcSEcCtD
Bretylium—Dizziness—Captopril—coronary artery disease	0.000201	0.00126	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000199	0.00591	CbGpPWpGaD
Bretylium—Vomiting—Telmisartan—coronary artery disease	0.000199	0.00125	CcSEcCtD
Bretylium—Nausea—Niacin—coronary artery disease	0.000198	0.00124	CcSEcCtD
Bretylium—Diarrhoea—Furosemide—coronary artery disease	0.000196	0.00123	CcSEcCtD
Bretylium—Feeling abnormal—Ramipril—coronary artery disease	0.000195	0.00123	CcSEcCtD
Bretylium—Dizziness—Perindopril—coronary artery disease	0.000195	0.00122	CcSEcCtD
Bretylium—Nausea—Pravastatin—coronary artery disease	0.000194	0.00122	CcSEcCtD
Bretylium—Gastrointestinal pain—Ramipril—coronary artery disease	0.000194	0.00122	CcSEcCtD
Bretylium—Vomiting—Captopril—coronary artery disease	0.000193	0.00121	CcSEcCtD
Bretylium—Dyspnoea—Lisinopril—coronary artery disease	0.000192	0.0012	CcSEcCtD
Bretylium—Feeling abnormal—Timolol—coronary artery disease	0.000191	0.0012	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.00019	0.00567	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.00019	0.00567	CbGpPWpGaD
Bretylium—Gastrointestinal pain—Timolol—coronary artery disease	0.00019	0.00119	CcSEcCtD
Bretylium—Dizziness—Furosemide—coronary artery disease	0.00019	0.00119	CcSEcCtD
Bretylium—Diarrhoea—Losartan—coronary artery disease	0.000189	0.00119	CcSEcCtD
Bretylium—Nausea—Trandolapril—coronary artery disease	0.000189	0.00119	CcSEcCtD
Bretylium—Nausea—Enalapril—coronary artery disease	0.000188	0.00118	CcSEcCtD
Bretylium—Vomiting—Perindopril—coronary artery disease	0.000188	0.00118	CcSEcCtD
Bretylium—Abdominal pain—Ramipril—coronary artery disease	0.000187	0.00118	CcSEcCtD
Bretylium—Body temperature increased—Ramipril—coronary artery disease	0.000187	0.00118	CcSEcCtD
Bretylium—Nausea—Telmisartan—coronary artery disease	0.000186	0.00117	CcSEcCtD
Bretylium—Body temperature increased—Timolol—coronary artery disease	0.000183	0.00115	CcSEcCtD
Bretylium—Abdominal pain—Timolol—coronary artery disease	0.000183	0.00115	CcSEcCtD
Bretylium—Dizziness—Losartan—coronary artery disease	0.000183	0.00115	CcSEcCtD
Bretylium—Vomiting—Furosemide—coronary artery disease	0.000182	0.00114	CcSEcCtD
Bretylium—Nausea—Captopril—coronary artery disease	0.00018	0.00113	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—IL1B—coronary artery disease	0.000177	0.00528	CbGpPWpGaD
Bretylium—Feeling abnormal—Lisinopril—coronary artery disease	0.000177	0.00111	CcSEcCtD
Bretylium—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000176	0.0011	CcSEcCtD
Bretylium—Vomiting—Losartan—coronary artery disease	0.000176	0.0011	CcSEcCtD
Bretylium—Nausea—Perindopril—coronary artery disease	0.000175	0.0011	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GPX3—coronary artery disease	0.000173	0.00515	CbGpPWpGaD
Bretylium—Nausea—Furosemide—coronary artery disease	0.00017	0.00107	CcSEcCtD
Bretylium—Abdominal pain—Lisinopril—coronary artery disease	0.00017	0.00107	CcSEcCtD
Bretylium—Body temperature increased—Lisinopril—coronary artery disease	0.00017	0.00107	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000169	0.00503	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000169	0.00503	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000169	0.00503	CbGpPWpGaD
Bretylium—Nausea—Losartan—coronary artery disease	0.000164	0.00103	CcSEcCtD
Bretylium—Diarrhoea—Ramipril—coronary artery disease	0.000162	0.00102	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.000162	0.00482	CbGpPWpGaD
Bretylium—Diarrhoea—Timolol—coronary artery disease	0.000159	0.000996	CcSEcCtD
Bretylium—Dizziness—Ramipril—coronary artery disease	0.000157	0.000985	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000156	0.00464	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000156	0.00464	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000156	0.00464	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GCLC—coronary artery disease	0.000156	0.00464	CbGpPWpGaD
Bretylium—Dizziness—Timolol—coronary artery disease	0.000153	0.000963	CcSEcCtD
Bretylium—Vomiting—Ramipril—coronary artery disease	0.000151	0.000947	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—TGFB2—coronary artery disease	0.000148	0.0044	CbGpPWpGaD
Bretylium—Vomiting—Timolol—coronary artery disease	0.000147	0.000926	CcSEcCtD
Bretylium—Diarrhoea—Lisinopril—coronary artery disease	0.000147	0.000924	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.000144	0.00428	CbGpPWpGaD
Bretylium—Dizziness—Lisinopril—coronary artery disease	0.000142	0.000893	CcSEcCtD
Bretylium—Nausea—Ramipril—coronary artery disease	0.000141	0.000885	CcSEcCtD
Bretylium—Nausea—Timolol—coronary artery disease	0.000138	0.000865	CcSEcCtD
Bretylium—Vomiting—Lisinopril—coronary artery disease	0.000137	0.000859	CcSEcCtD
Bretylium—SLC6A2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000133	0.00397	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000133	0.00395	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000133	0.00395	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—HSPA1A—coronary artery disease	0.00013	0.00387	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TNF—coronary artery disease	0.000129	0.00383	CbGpPWpGaD
Bretylium—Nausea—Lisinopril—coronary artery disease	0.000128	0.000802	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—GGT1—coronary artery disease	0.000122	0.00362	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.00012	0.00356	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000119	0.00354	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000119	0.00354	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000117	0.00347	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000115	0.00343	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000113	0.00337	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000109	0.00326	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTP1—coronary artery disease	0.000109	0.00325	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFBR2—coronary artery disease	0.000109	0.00325	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—HMOX1—coronary artery disease	0.000108	0.00321	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000102	0.00303	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTM1—coronary artery disease	0.0001	0.00299	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—HGF—coronary artery disease	0.0001	0.00299	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	9.94e-05	0.00296	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—AGER—coronary artery disease	9.69e-05	0.00288	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	9.5e-05	0.00283	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	9.5e-05	0.00283	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLN—coronary artery disease	9.24e-05	0.00275	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLG—coronary artery disease	8.65e-05	0.00257	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HK2—coronary artery disease	8.59e-05	0.00256	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	8.24e-05	0.00245	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	8.24e-05	0.00245	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	7.98e-05	0.00237	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOB—coronary artery disease	7.64e-05	0.00227	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	7.31e-05	0.00217	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	7.31e-05	0.00217	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	6.74e-05	0.00201	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	6.74e-05	0.00201	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HK1—coronary artery disease	6.74e-05	0.00201	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOA1—coronary artery disease	6.05e-05	0.0018	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	5.17e-05	0.00154	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	5.05e-05	0.0015	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CETP—coronary artery disease	4.99e-05	0.00149	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.79e-05	0.00143	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	4.73e-05	0.00141	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	4.4e-05	0.00131	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFB1—coronary artery disease	4.09e-05	0.00122	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	4.08e-05	0.00121	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLG—coronary artery disease	3.74e-05	0.00111	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	3.45e-05	0.00103	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOB—coronary artery disease	3.31e-05	0.000984	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.62e-05	0.000779	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.07e-05	0.000617	CbGpPWpGaD
